We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gum Arabic Detoxifies Gold Nanoparticles for Biomedical Use

By Biotechdaily staff writers
Posted on 14 Mar 2007
Nanotechnology researchers have used gum arabic as a matrix to stabilize and detoxify gold nanoparticles that can then be used for diagnostic or therapeutic purposes.

Gold nanoparticles (AuNPs) have exceptional stability against oxidation, and it is therefore expected that they will play a significant role in the progress of clinically useful diagnostic and therapeutic nanomedicines. More...
However, despite the huge potential for a new generation of AuNP-based nanomedicinal products, development of suitable, non-toxic AuNPs has proven to be difficult.

Gum arabic (GA) consists of a mixture of lower molecular weight polysaccharide and higher molecular weight hydroxyproline-rich glycoprotein. Because it is a mixture and the material varies significantly with source, the exact molecular structures are rather uncertain. Its glycoprotein is a high molecular weight hydroxyproline rich arabinogalactan with contiguous hydroxyprolines, oligo-alpha-1,3-L-arabinofurans, and non-contiguous hydroxyprolines galactose residues of oligo-arabinogalactans combining a beta-1,3-galactopyran core with rhamnoglucuronoarabinogalactose pentasaccharide side chains. The simultaneous presence of hydrophilic carbohydrate and hydrophobic protein provides its emulsification and stabilization properties. Emulsification is particularly enhanced due to molecular flexibility that allows greater surface interaction with the oil droplets.

In the current work, which was published in the February 2007 issue of Small, investigators from the University of Missouri (Columbia, USA) (1) used gum arabic to synthesize and stabilize nontoxic GA-AuNPs;(2) used GA-AuNPs for in vitro analysis and in vivo pharmacokinetics studies in pigs to gain insight into the organ-specific localization of this new generation of AuNP vector, and (3) performed x-ray computed tomography (CT) contrast measurements of GA-AuNP vectors to evaluate their potential utility in molecular imaging.

Results of these studies demonstrated that naturally occurring GA could be used as a nontoxic phytochemical construct in the production of readily administrable biocompatible AuNPs for diagnostic and therapeutic applications.
Senior author Dr. Kattesh Katti, professor of radiology and physics at the University of Missouri, said, "We found that gum arabic can effectively "lock” gold nanoparticles to produce nontoxic, nanoparticulate constructs that can be used for potential applications in nanomedicine. We have developed a new class of hybrid gold nanoparticles that are stable and can be administered either orally or through intravenous injection within the biological system.”


Related Links:
University of Missouri

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.